Orange Book product · Generic (ANDA)
TRANDOLAPRIL
TRANDOLAPRIL
At a glance
Jun 12, 2007
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 12, 2007
19 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
TRANDOLAPRIL
Strength
1MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 077522
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TRANDOLAPRIL
- 1996MAVIKBrand (NDA)
NDA 020528 · ABBVIE
- 2008TRANDOLAPRILGeneric (ANDA)
ANDA 078493 · SENORES PHARMS
- 2008TRANDOLAPRILGeneric (ANDA)
ANDA 078508 · EPIC PHARMA
- 2008TRANDOLAPRILGeneric (ANDA)
ANDA 078346 · PHARMOBEDIENT
- 2007TRANDOLAPRILGeneric (ANDA)
ANDA 078438 · AUROBINDO PHARMA
- 2007TRANDOLAPRILGeneric (ANDA)
ANDA 077307 · CHARTWELL MOLECULAR
- 2007TRANDOLAPRILGeneric (ANDA)
ANDA 077256 · EPIC PHARMA LLC
- 2007TRANDOLAPRILGeneric (ANDA)
ANDA 078320 · INVAGEN PHARMS
- 2007TRANDOLAPRILGeneric (ANDA)
ANDA 077805 · WATSON LABS
- 2006TRANDOLAPRILGeneric (ANDA)
ANDA 077489 · TEVA PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
